PharmaCielo Ltd. (TSXV: PCLO)

Market Cap	14.43M
Revenue (ttm)	1.62M
Net Income (ttm)	-14.15M
Shares Out	169.75M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185,020
Open	0.1100
Previous Close	0.1000
Day's Range	0.0850 - 0.1100
52-Week Range	0.0650 - 0.2900
Beta	2.44
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 27, 2024

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with B...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Marc Lustig
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: PCLO

Financial Performance

In 2023, PharmaCielo's revenue was 1.54 million, a decrease of -70.96% compared to the previous year's 5.31 million. Losses were -16.30 million, 12.3% more than in 2022.